BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9373465)

  • 1. Retinal changes associated with tamoxifen treatment for breast cancer.
    Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
    Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular toxicity in low-dose tamoxifen: a prospective study.
    Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystalline maculopathy: a rare complication of tamoxifen therapy.
    Srikantia N; Mukesh S; Krishnaswamy M
    J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
    Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
    Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen and ocular toxicity.
    Ah-Song R; Sasco AJ
    Cancer Detect Prev; 1997; 21(6):522-31. PubMed ID: 9398992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen retinopathy.
    Kaiser-Kupfer MI; Lippman ME
    Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal changes associated with tamoxifen treatment for breast cancer.
    Murray DC; Gibson JM
    Eye (Lond); 1998; 12 ( Pt 3a)():485-6. PubMed ID: 9775258
    [No Abstract]   [Full Text] [Related]  

  • 8. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity].
    Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P
    J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
    Salomão SR; Watanabe SE; Berezovsky A; Motono M
    Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular toxicity of tamoxifen.
    Gerner EW
    Ann Ophthalmol; 1989 Nov; 21(11):420-3. PubMed ID: 2619152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen-associated eye disease. A review.
    Nayfield SG; Gorin MB
    J Clin Oncol; 1996 Mar; 14(3):1018-26. PubMed ID: 8622006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE
    Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branch retinal vein occlusion associated with tamoxifen use.
    Onder Hİ; Kilic AC; Kose SA; Karatas A; Kaya E; Kaya M; Tunc M
    Semin Ophthalmol; 2013 Mar; 28(2):88-90. PubMed ID: 23448563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cysts in tamoxifen-treated women with breast cancer.
    Inal MM; Incebiyik A; Sanci M; Yildirim Y; Polat M; Pilanci B; Nayki C; Camuzcuoğlu H
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):104-6. PubMed ID: 15866095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and adjuvant tamoxifen treatment in breast cancer patients.
    Boehm DU; Lebrecht A; Eckhardt T; Albrich S; Schmidt M; Siggelkow W; Kandelhardt E; Koelbl H
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):500-6. PubMed ID: 19490009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and in vivo confocal microscopy findings in patients receiving tamoxifen citrate.
    Muftuoglu O; Uçakhan OO; Kanpolat A
    Eye Contact Lens; 2006 Sep; 32(5):228-32. PubMed ID: 16974155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.